Aslani, Baby Girl -.

HRN: 22-76-37  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/18/2024
CEFUROXIME 750MG (VIAL)
10/18/2024
10/24/2024
IV
330mg
Q8
Pcap
Waiting Final Action 
10/19/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/19/2024
10/26/2024
IVTT
100mg
Q8h
Amoebiasis
Waiting Final Action 
10/21/2024
CEFTRIAXONE 1G (VIAL)
10/21/2024
10/27/2024
IV
980
Q24
Pcap
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: